Clinical Trial Update: Study to Evaluate SYN115 in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating SYN115 in Parkinson's disease has completed. The update provides no efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SYN115

Snippet

Sponsor: Biotie Therapies Inc. | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED